Clinical trial
Does Intranasal Insulin Administration Reduce the Incidence of Cognitive Dysfunction After Cardiac Surgery?
NCT03415061 is registered in ClinicalTrials.gov with Hiroaki Sato, MD., PhD. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Does Intranasal Insulin Administration Reduce the Incidence of Cognitive Dysfunction After Cardiac Surgery?
- Lead sponsor
- Hiroaki Sato, MD., PhD.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 1, 2021
- Completion date
- November 30, 2024
- Enrollment
- 494 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.